These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10201659)

  • 21. Does lowering cholesterol cause cancer?
    Dalen JE; Dalton WS
    JAMA; 1996 Jan; 275(1):67-9. PubMed ID: 8531290
    [No Abstract]   [Full Text] [Related]  

  • 22. Lipid lowering drugs prescription and the risk of peripheral neuropathy: an exploratory case-control study using automated databases.
    Corrao G; Zambon A; Bertù L; Botteri E; Leoni O; Contiero P
    J Epidemiol Community Health; 2004 Dec; 58(12):1047-51. PubMed ID: 15547071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular telephones and cancer--a nationwide cohort study in Denmark.
    Johansen C; Boice J; McLaughlin J; Olsen J
    J Natl Cancer Inst; 2001 Feb; 93(3):203-7. PubMed ID: 11158188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implantable cardioverter-defibrillators and subsequent cancer risk: a nationwide population-based cohort study.
    Pedersen SB; Nielsen JC; Bøtker HE; Farkas DK; Schmidt M; Sørensen HT
    Europace; 2015 Jun; 17(6):902-8. PubMed ID: 25840286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Management of Dyslipidaemia in Patients with Type 2 Diabetes Mellitus Receiving Lipid-Lowering Drugs: A Sub-Analysis of the CEPHEUS Findings.
    Shehab A; Al-Rasadi K; Arafah M; Al-Hinai AT; Al Mahmeed W; Bhagavathula AS; Al Tamimi O; Al Herz S; Al Anazi F; Al Nemer K; Metwally O; Alkhadra A; Fakhry M; Elghetany H; Medani AR; Yusufali AH; Al Jassim O; Al Hallaq O; Baslaib FOAS; Alawadhi M; Amin H; Al-Hashmi K; Oulhaj A
    Curr Vasc Pharmacol; 2018; 16(4):368-375. PubMed ID: 28677510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid-lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: A real-world observational analysis of a health claims database.
    Kawasaki R; Konta T; Nishida K
    Diabetes Obes Metab; 2018 Oct; 20(10):2351-2360. PubMed ID: 29790265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO.
    Nag SS; Daniel GW; Bullano MF; Kamal-Bahl S; Sajjan SG; Hu H; Alexander C
    J Manag Care Pharm; 2007 Oct; 13(8):652-63. PubMed ID: 17970603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candida infection and cancer risk: a Danish nationwide cohort study.
    Nørgaard M; Thomsen RW; Farkas DK; Mogensen MF; Sørensen HT
    Eur J Intern Med; 2013 Jul; 24(5):451-5. PubMed ID: 23522963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer mortality according to lipid-lowering drugs and lipoproteins in a general population.
    Bérard E; Bongard V; Dallongeville J; Arveiler D; Ruidavets JB; Ferrières J
    Curr Med Res Opin; 2011 Oct; 27(10):1963-71. PubMed ID: 21899411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Major trauma in elderly adults receiving lipid-lowering medications.
    Redelmeier DA; Naylor CD; Brenneman FD; Sharkey PW; Juurlink DN
    J Trauma; 2001 Apr; 50(4):678-83. PubMed ID: 11303164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimisation of quality indicators for lipid-lowering treatment of type 2 diabetes mellitus.
    Madsen MM; Kærsvang L; Hansen AW; Flink M; Nielsen HK; Hansen KW
    Dan Med J; 2018 Sep; 65(9):. PubMed ID: 30187860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer risk and mortality in users of calcium channel blockers. A cohort study.
    Sørensen HT; Olsen JH; Mellemkjaer L; Marie A; Steffensen FH; McLaughlin JK; Baron JA
    Cancer; 2000 Jul; 89(1):165-70. PubMed ID: 10897013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age- and gender-related differences in the use of secondary medical prevention after primary vascular surgery: a nationwide follow-up study.
    Høgh A; Lindholt JS; Nielsen H; Jensen LP; Johnsen SP
    Eur J Vasc Endovasc Surg; 2012 Mar; 43(3):300-7. PubMed ID: 22244910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey.
    Primatesta P; Poulter NR
    BMJ; 2000 Nov; 321(7272):1322-5. PubMed ID: 11090516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extroversion and neuroticism and the associated risk of cancer: A Danish cohort study.
    Schapiro IR; Ross-Petersen L; Saelan H; Garde K; Olsen JH; Johansen C
    Am J Epidemiol; 2001 Apr; 153(8):757-63. PubMed ID: 11296147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid-lowering medication and risk of injury.
    Bovbjerg VE; Siscovick DS; Psaty BM; McCann BS; Koepsell TD; Raghunathan TE; Wagner EH
    J Clin Epidemiol; 1999 Dec; 52(12):1197-200. PubMed ID: 10580782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of lipid-lowering medications in outpatients with coronary heart disease in the Department of Veterans Affairs System.
    Rubins HB; Nelson DB; Noorbaloochi S; Nugent S
    Am J Cardiol; 2003 Nov; 92(10):1177-82. PubMed ID: 14609592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of aspirin, beta-blockers, and lipid-lowering medications before recurrent acute myocardial infarction: missed opportunities for prevention?
    McCormick D; Gurwitz JH; Lessard D; Yarzebski J; Gore JM; Goldberg RJ
    Arch Intern Med; 1999 Mar; 159(6):561-7. PubMed ID: 10090112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inverse relationship between lipid-lowering drugs and saturated fat intake in US adults.
    Mann DM; Natarajan S
    Cardiovasc Drugs Ther; 2007 Apr; 21(2):109-15. PubMed ID: 17372816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated?
    Mantel-Teeuwisse AK; Klungel OH; Verschuren WM; Porsius AJ; de Boer A
    Br J Clin Pharmacol; 2002 Apr; 53(4):379-85. PubMed ID: 11966669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.